MyMD Pharmaceuticals, Inc. (MYMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.2M |
| Enterprise Value | 2.21M |
| P/E Ratio | -0.18 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.32 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.31 |
| Return On Equity | -0.6 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -9.85M |
| Net Income | -14.98M |
| Diluted EPS | -8.66 |
| Total Cash | -19,294 |
| Total Cash/Share | 1.61 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.71 |
| Book Value Per Share | 2.94 |
| 52-Week Change | -94.61 |
| 52-Week High | 63.9 |
| 52-Week Low | 1.75 |
| Moving Average 50 Days | 2 |
| Moving Average 200 Days | 5.24 |
| Average Volume | 61,809 |
| Shares Outstanding | 2.37M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:30 |
| Last Split Date | February 15, 2024 |